These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 17286527

  • 1. Facility variation in utilization of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and chronic kidney disease.
    Tiwari A, Tseng CL, Kern EF, Maney M, Miller DR, Pogach L.
    Am J Manag Care; 2007 Feb; 13(2):73-9. PubMed ID: 17286527
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [Abstract] [Full Text] [Related]

  • 3. Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment.
    Penne EL, Neumann J, Klein IH, Oey PL, Bots ML, Blankestijn PJ.
    J Nephrol; 2009 Jun; 22(2):208-15. PubMed ID: 19384838
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

  • 5. Effects of the Renin-Angiotensin system blockade on hemoglobin levels in type 2 diabetic patients with chronic kidney disease.
    Inoue A, Babazono T, Iwamoto Y.
    Am J Hypertens; 2008 Mar; 21(3):317-22. PubMed ID: 18202667
    [Abstract] [Full Text] [Related]

  • 6. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 7. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 8. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.
    Nephrol Dial Transplant; 2009 May 20; 24(5):1663-71. PubMed ID: 19145003
    [Abstract] [Full Text] [Related]

  • 9. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.
    Wang PT, Huang YB, Lin MY, Chuang PF, Hwang SJ.
    Kaohsiung J Med Sci; 2012 Sep 20; 28(9):477-83. PubMed ID: 22974666
    [Abstract] [Full Text] [Related]

  • 10. Usual ACE inhibitor therapy in CKD patients is associated with lower plasma aldosterone levels than usual angiotensin receptor blocker therapy.
    Haddad N, Rajan J, Nagaraja HN, Agarwal AK, Hebert LA.
    Kidney Blood Press Res; 2007 Sep 20; 30(5):299-305. PubMed ID: 17641546
    [Abstract] [Full Text] [Related]

  • 11. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A, Djurdjev O, Beaulieu M, Er L.
    Am J Kidney Dis; 2008 Oct 20; 52(4):661-71. PubMed ID: 18805347
    [Abstract] [Full Text] [Related]

  • 12. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul 20; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 13. Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation.
    Thilly N, Bayat S, Alla F, Kessler M, Briançon S, Frimat L.
    Clin Transplant; 2008 Jul 20; 22(4):439-46. PubMed ID: 18318741
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure.
    Brackbill ML, Bashaw-Keaton R, Sytsma CS.
    Am J Manag Care; 2007 Oct 20; 13(10):568-70. PubMed ID: 17927461
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
    Jennings DL, Kalus JS, Coleman CI, Manierski C, Yee J.
    Diabet Med; 2007 May 20; 24(5):486-93. PubMed ID: 17367311
    [Abstract] [Full Text] [Related]

  • 16. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
    Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moyé LA, Pfeffer MA, Solomon SD.
    Circulation; 2004 Dec 14; 110(24):3667-73. PubMed ID: 15569840
    [Abstract] [Full Text] [Related]

  • 17. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, Crooks P.
    Am J Kidney Dis; 2009 Mar 14; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [Abstract] [Full Text] [Related]

  • 18. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Jan 14; 16(1):55-64. PubMed ID: 16470693
    [Abstract] [Full Text] [Related]

  • 19. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
    Ozturk S, Sar F, Bengi-Bozkurt O, Kazancioglu R.
    Kidney Blood Press Res; 2009 Jan 14; 32(4):268-75. PubMed ID: 19776644
    [Abstract] [Full Text] [Related]

  • 20. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS, Chang SH, Chang GJ, Liu JR, Chan YH, Lee HF, Wen MS, Chen WJ, Yeh YH, Kuo CT, See LC.
    Cardiovasc Diabetol; 2016 Apr 02; 15():56. PubMed ID: 27039185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.